DGX Quest Diagnostics Inc

Price (delayed)

$124.39

Market cap

$16.76B

P/E Ratio

15.17

Dividend/share

$2.21

EPS

$8.2

Enterprise value

$20.31B

Sector: Healthcare
Industry: Diagnostics & Research

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights

Quest Diagnostics's quick ratio has surged by 65% YoY and by 10% QoQ
DGX's EPS has surged by 52% year-on-year and by 47% since the previous quarter
Quest Diagnostics's debt has increased by 13% YoY

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
134.77M
Market cap
$16.76B
Enterprise value
$20.31B
Valuations
Price to earnings (P/E)
15.17
Price to book (P/B)
2.61
Price to sales (P/S)
2.01
EV/EBIT
12.6
EV/EBITDA
10.38
EV/Sales
2.43
Earnings
Revenue
$8.36B
EBIT
$1.61B
EBITDA
$1.96B
Free cash flow
$1.48B
Per share
EPS
$8.2
Free cash flow per share
$10.93
Book value per share
$47.65
Revenue per share
$61.93
TBVPS
$44.97
Balance sheet
Total assets
$14.14B
Total liabilities
$7.7B
Debt
$5.15B
Equity
$6.4B
Working capital
$959M
Liquidity
Debt to equity
0.8
Current ratio
1.4
Quick ratio
1.27
Net debt/EBITDA
1.81
Margins
EBITDA margin
23.4%
Gross margin
36.2%
Net margin
13.2%
Operating margin
18.4%
Efficiency
Return on assets
8.5%
Return on equity
18.8%
Return on invested capital
22.1%
Return on capital employed
13.7%
Return on sales
19.3%
Dividend
Dividend yield
1.78%
DPS
$2.21
Payout ratio
27%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-0.46%
1 week
1.15%
1 month
-0.09%
1 year
16.55%
YTD
4.38%
QTD
4.38%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$8.36B
Gross profit
$3.03B
Operating income
$1.54B
Net income
$1.11B
Gross margin
36.2%
Net margin
13.2%
The net income has soared by 51% YoY and by 47% from the previous quarter
DGX's operating income is up by 41% year-on-year and by 36% since the previous quarter
Quest Diagnostics's net margin has increased by 38% YoY and by 32% QoQ
The company's operating margin rose by 30% YoY and by 22% QoQ

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
P/E
15.17
P/B
2.61
P/S
2.01
EV/EBIT
12.6
EV/EBITDA
10.38
EV/Sales
2.43
DGX's EPS has surged by 52% year-on-year and by 47% since the previous quarter
DGX's price to earnings (P/E) is 13% lower than its 5-year quarterly average of 17.5 and 6% lower than its last 4 quarters average of 16.2
Quest Diagnostics's equity has increased by 14% YoY and by 10% from the previous quarter
The stock's price to book (P/B) is 9% more than its last 4 quarters average of 2.4
The stock's price to sales (P/S) is 12% more than its 5-year quarterly average of 1.8 and 12% more than its last 4 quarters average of 1.8
The revenue has grown by 11% from the previous quarter and by 9% YoY

Efficiency

How efficient is Quest Diagnostics business performance
DGX's ROE is up by 42% since the previous quarter and by 38% year-on-year
DGX's return on assets is up by 42% since the previous quarter and by 35% year-on-year
Quest Diagnostics's return on invested capital has increased by 36% QoQ and by 20% YoY
DGX's return on sales is up by 31% year-on-year and by 27% since the previous quarter

Dividends

What is DGX's dividend history
DPS
$2.21
Dividend yield
1.78%
Payout ratio
27%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 84% greater than the total liabilities
Quest Diagnostics's quick ratio has surged by 65% YoY and by 10% QoQ
The current ratio has soared by 59% YoY and by 9% QoQ
Quest Diagnostics's debt is 20% lower than its equity
Quest Diagnostics's equity has increased by 14% YoY and by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.